Regenerative Biology: Adjustments in core technical personnel, adding Dr. Huang Jie and Dr. Hao Jia.

Regen Biotech announced that, according to the company's strategy and layout of R&D projects, core technical personnel will be restructured. Dr. Huang Jie and Dr. Hao Jia have been newly identified as core technical personnel, while former core technical personnel Chen Suhong and Xu Zhihui will continue to work at the company. This adjustment does not involve any disputes over the ownership of patented inventions and does not affect the integrity of the company's patent ownership, nor will it have a substantial impact on the company's core competitiveness; rather, it will help to advance R&D projects and the development of innovative drug pipelines.